A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...
Absent any statutory consequences for not completing the OPPS Drug Acquisition Cost Survey (ODACS), it is wrong for CMS to tell hospitals and health systems that they “are to” complete it.